bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Table 3 from Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium
Authors: Cheng Iona , Shariff-Marco Salma , Koo Jocelyn , Monroe Kristine R. , Yang Juan , John Esther M. , Kurian Allison W. , Kwan Marilyn L. , Henderson Brian E. , Bernstein Leslie , Lu Yani , Sposto Richard , Vigen Cheryl , Wu Anna H. , Gomez Scarlett Lin , Keegan Theresa H.M.
Published: April 2023

Supplemental Table 3. Sociodemographic characteristics of the California Breast Cancer Survivorship Consortium by pre-diagnosis BMI.
Supplemental Table 1 from Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium
Authors: Cheng Iona , Shariff-Marco Salma , Koo Jocelyn , Monroe Kristine R. , Yang Juan , John Esther M. , Kurian Allison W. , Kwan Marilyn L. , Henderson Brian E. , Bernstein Leslie , Lu Yani , Sposto Richard , Vigen Cheryl , Wu Anna H. , Gomez Scarlett Lin , Keegan Theresa H.M.
Published: April 2023

Supplemental Table 1. Neighborhood characteristics of the California Breast Cancer Survivorship Consortium by pre-diagnosis BMI.
Supplementary Data from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
Authors: Okayama Hirokazu , Schetter Aaron J. , Ishigame Teruhide , Robles Ana I. , Kohno Takashi , Yokota Jun , Takenoshita Seiichi , Harris Curtis C.
Published: April 2023

Supplementary Data. This excel file contains all of the data on stage I lung adenocarcinoma that was used for this manuscript. The second worksheet contains a description of the columns
Supplemental Table 1 from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
Authors: Okayama Hirokazu , Schetter Aaron J. , Ishigame Teruhide , Robles Ana I. , Kohno Takashi , Yokota Jun , Takenoshita Seiichi , Harris Curtis C.
Published: April 2023

Supplemental Table 1. Datasets considered for inclusion in the meta-analysis and the rationale for inclusion or exclusion.
Supplemental Table 2 from Contextual Impact of Neighborhood Obesogenic Factors on Postmenopausal Breast Cancer: The Multiethnic Cohort
Authors: Conroy Shannon M. , Clarke Christina A. , Yang Juan , Shariff-Marco Salma , Shvetsov Yurii B. , Park Song-Yi , Albright Cheryl L. , Hertz Andrew , Monroe Kristine R. , Kolonel Laurence N. , Marchand Loïc Le , Wilkens Lynne R. , Gomez Scarlett Lin , Cheng Iona
Published: April 2023

Distributions of obesogenic neighborhood factors by race/ethnicity, postmenopausal women residing in California at baseline (n=48,247), Multiethnic Cohort, 1993-2010.
Supplemental Figure 1 from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
Authors: Okayama Hirokazu , Schetter Aaron J. , Ishigame Teruhide , Robles Ana I. , Kohno Takashi , Yokota Jun , Takenoshita Seiichi , Harris Curtis C.
Published: April 2023

Supplemental Figure 1. Nomogram to predict 5-year survival rates for stage IA (A) or stage IB (B) lung adenocarcinoma separately. Each clinical variable (4-gene score, sex and age) is assigned a point value. The sum of those points can then be used to estimate probability of survival for 5-years.
Supplementary Table S1 from Folate Pathway Gene Polymorphisms, Maternal Folic Acid Use, and Risk of Childhood Acute Lymphoblastic Leukemia
Authors: Milne Elizabeth , Greenop Kathryn R. , Scott Rodney J. , Haber Michelle , Norris Murray D. , Attia John , Jamieson Sarra E. , Miller Margaret , Bower Carol , Bailey Helen D. , Dawson Somer , McCowage Geoffrey B. , de Klerk Nicholas H. , van Bockxmeer Frank M. , Armstrong Bruce K.
Published: April 2023

Supplementary Table S1. Mother's folate pathway genotypes and risk of ALL by immunophenotype and cytogenetic subtype
Supplementary Table S6 from Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium
Authors: Marks Morgan A. , Chaturvedi Anil K. , Kelsey Karl , Straif Kurt , Berthiller Julien , Schwartz Stephen M. , Smith Elaine , Wyss Annah , Brennan Paul , Olshan Andrew F. , Wei Qingyi , Sturgis Erich M. , Zhang Zuo-Feng , Morgenstern Hal , Muscat Joshua , Lazarus Philip , McClean Michael , Chen Chu , Vaughan Thomas L. , Wunsch-Filho Victor , Curado Maria Paula , Koifman Sergio , Matos Elena , Menezes Ana , Daudt Alexander W. , Fernandez Leticia , Posner Marshall , Boffetta Paolo , Lee Yuan-Chin Amy , Hashibe Mia , D'Souza Gypsyamber
Published: April 2023

Sensitivity analysis of the effect of misclassification of marijuana use exposure on the univariate association of ever marijuana use with oropharyngeal cancer
Supplementary Table S3 from Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium
Authors: Marks Morgan A. , Chaturvedi Anil K. , Kelsey Karl , Straif Kurt , Berthiller Julien , Schwartz Stephen M. , Smith Elaine , Wyss Annah , Brennan Paul , Olshan Andrew F. , Wei Qingyi , Sturgis Erich M. , Zhang Zuo-Feng , Morgenstern Hal , Muscat Joshua , Lazarus Philip , McClean Michael , Chen Chu , Vaughan Thomas L. , Wunsch-Filho Victor , Curado Maria Paula , Koifman Sergio , Matos Elena , Menezes Ana , Daudt Alexander W. , Fernandez Leticia , Posner Marshall , Boffetta Paolo , Lee Yuan-Chin Amy , Hashibe Mia , D'Souza Gypsyamber
Published: April 2023

Association of marijuana use and oral tongueâ€ cancer stratified smoking/drinking intensity
Supplementary Figure 8 from Effects of Preanalytic Variables on Circulating MicroRNAs in Whole Blood
Authors: Zhao Hua , Shen Jie , Hu Qiang , Davis Warren , Medico Leonardo , Wang Dan , Yan Li , Guo Yuqing , Liu Biao , Qin Maochun , Nesline Mary , Zhu Qianqian , Yao Song , Ambrosone Christine B. , Liu Song
Published: April 2023

Supplementary Figure 8 - The effects of storage duration (baseline vs. 6 months) on the circulation level of miR-16 in plasma of cases and controls, separately.
Supplementary Table S1 from The Role of Stage at Diagnosis in Colorectal Cancer Black–White Survival Disparities: A Counterfactual Causal Inference Approach
Authors: Valeri Linda , Chen Jarvis T. , Garcia-Albeniz Xabier , Krieger Nancy , VanderWeele Tyler J. , Coull Brent A.
Published: April 2023

Supplementary Table S1. Description of Tumor Characteristics and SEER data codes
Supplementary Table 2 from Gene Set Analysis of Survival Following Ovarian Cancer Implicates Macrolide Binding and Intracellular Signaling Genes
Authors: Fridley Brooke L. , Jenkins Gregory D. , Tsai Ya-Yu , Song Honglin , Bolton Kelly L. , Fenstermacher David , Tyrer Jonathan , Ramus Susan J. , Cunningham Julie M. , Vierkant Robert A. , Chen Zhihua , Chen Y. Ann , Iversen Ed , Menon Usha , Gentry-Maharaj Aleksandra , Schildkraut Joellen , Sutphen Rebecca , Gayther Simon A. , Hartmann Lynn C. , Pharoah Paul D.P. , Sellers Thomas A. , Goode Ellen L.
Published: April 2023

PDF file - 130K
Supplementary Table S3 from Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis
Authors: Meulen Miriam P. van der , Kapidzic Atija , Leerdam Monique E. van , van der Steen Alex , Kuipers Ernst J. , Spaander Manon C.W. , de Koning Harry J. , Hol Lieke , Lansdorp-Vogelaar Iris
Published: April 2023

Screening strategies on the cost efficiency frontier with uniform screening and all combined strategies for screening stratified by gender, 3% discounted
Supplementary Figure S1 from Improving Power to Detect Changes in Blood miRNA Expression by Accounting for Sources of Variability in Experimental Designs
Authors: Daniels Sarah I. , Sillé Fenna C.M. , Goldbaum Audrey , Yee Brenda , Key Ellen F. , Zhang Luoping , Smith Martyn T. , Thomas Reuben
Published: April 2023

Supplementary Figure S1A and S1B: miR Extraction Methods Comparison
Supplemental Tables from Interactions between Ultraviolet Light and MC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes
Authors: Barón Anna E. , Asdigian Nancy L. , Gonzalez Victoria , Aalborg Jenny , Terzian Tamara , Stiegmann Regan A. , Torchia Enrique C. , Berwick Marianne , Dellavalle Robert P. , Morelli Joseph G. , Mokrohisky Stefan T. , Crane Lori A. , Box Neil F.
Published: April 2023

Table S1. Summary of number of participants in skin exams and interviews over study period. Table S2: Characteristics of study participants providing data for each study year (total n=477). Table S3. rs12913832 and MC1R genotypes by sex, ethnicity and pigmentation phenotype. TableS4. rs12913832 genotypes and exposure characteristics of the study population. Table S5. MC1R genotypes and exposure characteristics of the study population. Table S6. Effect of cumulative Chronic UV Exposure on Total Body Nevus Counts (2004 - 2008) by Intermittent UV Exposure Subgroup. Table S7. Effect of Cumulative Number of Waterside Vacations on Total Body Nevus Counts (2004-2008) by Genotype. Table S8. Effect of Cumulative Number of Sunburns on Counts of Nevi >2 mm by Genotype Subgroup. Table S9. Effect of Cumulative Number of Waterside Vacations on Facial Freckling Density Level (2004-2008) by Genotype Subgroup.
Supplementary Material from Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results
Authors: Isidean Sandra D. , Mayrand Marie-Hélène , Ramanakumar Agnihotram V. , Rodrigues Isabel , Ferenczy Alex , Ratnam Sam , Coutlée François , Franco Eduardo L.
Published: April 2023

Supplemental Table 1. Performance of Triage Strategies for the Detection of CIN3+ Among HR-HPV+ Women. Supplemental Table 2. Performance of Additional Triage Strategies for the Detection of CIN2+ Among HR-HPV+ Women.
Supplementary Tables 1 - 4 from Oral Hygiene and Risk of Nasopharyngeal Carcinoma—A Population-Based Case–Control Study in China
Authors: Liu Zhiwei , Chang Ellen T. , Liu Qing , Cai Yonglin , Zhang Zhe , Chen Guomin , Xie Shang-Hang , Cao Su-Mei , Shao Jian-Yong , Jia Wei-Hua , Zheng Yuming , Liao Jian , Chen Yufeng , Ernberg Ingemar , Vaughan Thomas L. , Adami Hans-Olov , Huang Guangwu , Zeng Yi , Zeng Yi-Xin , Ye Weimin
Published: April 2023

Supplementary Tables 1-4. Supplementary Table 1. Odds ratios (ORs) and 95% confidence intervals (CIs) of nasopharyngeal carcinoma (NPC) associated with oral health among ever smokers in southern China (2010-2014). Supplementary Table 2. Stratified odds ratios (ORs) and 95% confidence intervals (CIs) of nasopharyngeal carcinoma (NPC) associated with number of teeth lost after age 20 years.* Supplementary Table 3. Stratified odds ratios (ORs) and 95% confidence intervals (CIs)of nasopharyngeal carcinoma (NPC) associated with frequency of tooth brushing.* Supplementary Table 4. Odds ratios (ORs) and 95% confidence intervals (CIs) of nasopharyngeal carcinoma (NPC) associated with oral health in southern China - restricted to cases interviewed within 30 days of diagnosis (2010-2014).
Supplementary Figure 1s from The Impact of DNA Input Amount and DNA Source on the Performance of Whole-Exome Sequencing in Cancer Epidemiology
Authors: Zhu Qianqian , Hu Qiang , Shepherd Lori , Wang Jianmin , Wei Lei , Morrison Carl D. , Conroy Jeffrey M. , Glenn Sean T. , Davis Warren , Kwan Marilyn L. , Ergas Isaac J. , Roh Janise M. , Kushi Lawrence H. , Ambrosone Christine B. , Liu Song , Yao Song
Published: April 2023

Supplementary Figure 1s. Comparisons of quality metrics between concordant and discordant single nucleotide variants (SNVs).
Supplementary Table 3 from Aristolochic Acid in the Etiology of Renal Cell Carcinoma
Authors: Hoang Margaret L. , Chen Chung-Hsin , Chen Pau-Chung , Roberts Nicholas J. , Dickman Kathleen G. , Yun Byeong Hwa , Turesky Robert J. , Pu Yeong-Shiau , Vogelstein Bert , Papadopoulos Nickolas , Grollman Arthur P. , Kinzler Kenneth W. , Rosenquist Thomas A.
Published: April 2023

Primers used for Sanger sequencing
Supplementary Table 2 from Aristolochic Acid in the Etiology of Renal Cell Carcinoma
Authors: Hoang Margaret L. , Chen Chung-Hsin , Chen Pau-Chung , Roberts Nicholas J. , Dickman Kathleen G. , Yun Byeong Hwa , Turesky Robert J. , Pu Yeong-Shiau , Vogelstein Bert , Papadopoulos Nickolas , Grollman Arthur P. , Kinzler Kenneth W. , Rosenquist Thomas A.
Published: April 2023

Somatic mutations identified from exome sequencing of ten Taiwanese ccRCC patients
Supplementary Methods and Supplementary Figure Legend from Aristolochic Acid in the Etiology of Renal Cell Carcinoma
Authors: Hoang Margaret L. , Chen Chung-Hsin , Chen Pau-Chung , Roberts Nicholas J. , Dickman Kathleen G. , Yun Byeong Hwa , Turesky Robert J. , Pu Yeong-Shiau , Vogelstein Bert , Papadopoulos Nickolas , Grollman Arthur P. , Kinzler Kenneth W. , Rosenquist Thomas A.
Published: April 2023

Online methods and figures
Supplementary Data from Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma
Authors: Lu Bin , Ma Yunchao , Wu Guobin , Tong Xin , Guo Huaizu , Liang Anmin , Cong Wenming , Liu Chang , Wang Hao , Wu Mengchao , Zhao Jian , Guo Yajun
Published: April 2023

Supplementary Data from Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma
Supplementary Figures S1-S4 from Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy
Authors: Hingorani Mohan , White Christine L. , Zaidi Shane , Merron Andrew , Peerlinck Inge , Gore Martin E. , Nutting Christopher M. , Pandha Hardev S. , Melcher Alan A. , Vile Richard G. , Vassaux Georges , Harrington Kevin J.
Published: April 2023

Supplementary Figures S1-S4 from Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy
Supplementary Tables S1-S5 from Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis
Authors: Yu Dianke , Zhang Xuemei , Liu Ju , Yuan Peng , Tan Wen , Guo Yongli , Sun Tong , Zhao Dan , Yang Ming , Liu Junniao , Xu Binghe , Lin Dongxin
Published: April 2023

Supplementary Tables S1-S5 from Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis
Supplementary Tables S1-S2 from Expression of Prenylated Rab Acceptor 1 Domain Family, Member 2 (PRAF2) in Neuroblastoma: Correlation with Clinical Features, Cellular Localization, and Cerulenin-Mediated Apoptosis Regulation
Authors: Geerts Dirk , Wallick Christopher J. , Koomoa Dana-Lynn T. , Koster Jan , Versteeg Rogier , Go Ramon Christopher V. , Bachmann André S.
Published: April 2023

Supplementary Tables S1-S2 from Expression of Prenylated Rab Acceptor 1 Domain Family, Member 2 (PRAF2) in Neuroblastoma: Correlation with Clinical Features, Cellular Localization, and Cerulenin-Mediated Apoptosis Regulation
Supplementary Data from Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer
Authors: Hong Tse-Ming , Chen Yuh-Ling , Wu Yi-Ying , Yuan Ang , Chao Yu-Chih , Chung Yi-Chuan , Wu Ming-Heng , Yang Shuenn-Chen , Pan Szu-Hua , Shih Jin-Yuan , Chan Wing-Kai , Yang Pan-Chyr
Published: April 2023

Supplementary Data from Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer
Supplementary Figures S1-S2 from Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells
Authors: Boller Danielle , Schramm Alexander , Doepfner Kathrin T. , Shalaby Tarek , von Bueren André O. , Eggert Angelika , Grotzer Michael A. , Arcaro Alexandre
Published: April 2023

Supplementary Figures S1-S2 from Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells
Supplementary Data from Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
Authors: Solit David B. , Osman Iman , Polsky David , Panageas Katherine S. , Daud Adil , Goydos James S. , Teitcher Jerrold , Wolchok Jedd D. , Germino F. Joseph , Krown Susan E. , Coit Daniel , Rosen Neal , Chapman Paul B.
Published: April 2023

Supplementary Data from Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
Supplementary Figure S1 from Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
Authors: van Cruijsen Hester , van der Veldt Astrid A.M. , Vroling Laura , Oosterhoff Dinja , Broxterman Henk J. , Scheper Rik J. , Giaccone Giuseppe , Haanen John B.A.G. , van den Eertwegh Alfons J.M. , Boven Epie , Hoekman Klaas , de Gruijl Tanja D.
Published: April 2023

Supplementary Figure S1 from Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
Supplementary Table S2 from Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer
Authors: Kawanishi Hiroaki , Matsui Yoshiyuki , Ito Masaaki , Watanabe Jun , Takahashi Takeshi , Nishizawa Koji , Nishiyama Hiroyuki , Kamoto Toshiyuki , Mikami Yoshiki , Tanaka Yoshinori , Jung Giman , Akiyama Hideo , Nobumasa Hitoshi , Guilford Parry , Reeve Anthony , Okuno Yasushi , Tsujimoto Gozoh , Nakamura Eijiro , Ogawa Osamu
Published: April 2023

Supplementary Table S2 from Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer
Supplementary Table S2 from Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
Authors: Desmedt Christine , Haibe-Kains Benjamin , Wirapati Pratyaksha , Buyse Marc , Larsimont Denis , Bontempi Gianluca , Delorenzi Mauro , Piccart Martine , Sotiriou Christos
Published: April 2023

Supplementary Table S2 from Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
Supplementary Data from Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
Authors: Briasoulis Evangelos , Pappas Periklis , Puozzo Christian , Tolis Christos , Fountzilas George , Dafni Urania , Marselos Marios , Pavlidis Nicholas
Published: April 2023

Supplementary Data from Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
Supplementary Data from Novel Strategies for Granulocyte Colony-Stimulating Factor Treatment of Severe Prolonged Neutropenia Suggested by Mathematical Modeling
Authors: Shochat Eliezer , Rom-Kedar Vered
Published: April 2023

Supplementary Data from Novel Strategies for Granulocyte Colony-Stimulating Factor Treatment of Severe Prolonged Neutropenia Suggested by Mathematical Modeling
CCR Translation on this Article from A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia
Authors: Tsai Donald E. , Luger Selina M. , Andreadis Charalambos , Vogl Dan T. , Kemner Allison , Potuzak Melissa , Goradia Ami , Loren Alison W. , Perl Alexander E. , Schuster Stephen J. , Porter David L. , Stadtmauer Edward A. , Goldstein Steven C. , Thompson James E. , Swider Cezary , Bagg Adam , Mato Anthony R. , Carroll Martin
Published: April 2023

CCR Translation on this Article from A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia
Supplementary Figure 8 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
Authors: Azim Hatem A. , Michiels Stefan , Bedard Philippe L. , Singhal Sandeep K. , Criscitiello Carmen , Ignatiadis Michail , Haibe-Kains Benjamin , Piccart Martine J. , Sotiriou Christos , Loi Sherene
Published: April 2023

PDF file - 82K
Supplementary Table 2 from New Gene-Immunotherapy Combining TRAIL-Lymphocytes and EpCAMxCD3 Bispecific Antibody for Tumor Targeting
Authors: Groth Ariane , Salnikov Alexei V. , Ottinger Sabine , Gladkich Jury , Liu Li , Kallifatidis Georgios , Salnikova Olga , Ryschich Eduard , Giese Nathalia , Giese Thomas , Momburg Frank , Büchler Markus W. , Moldenhauer Gerhard , Herr Ingrid
Published: April 2023

PDF file - 85K
Supplementary Figure 1 from Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients
Authors: Servais Elliot L. , Colovos Christos , Rodriguez Luis , Bograd Adam J. , Nitadori Jun-ichi , Sima Camelia , Rusch Valerie W. , Sadelain Michel , Adusumilli Prasad S.
Published: April 2023

PDF file - 546K
CCR Translation for This Article from Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus
Authors: Lee Chee Khoon , Marschner Ian C. , Simes R. John , Voysey Merryn , Egleston Brian , Hudes Gary , de Souza Paul
Published: April 2023

CCR Translation for This Article from Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus
Supplementary Table 3 from Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic Instability
Authors: Crago Aimee M. , Socci Nicholas D. , DeCarolis Penelope , O'Connor Rachael , Taylor Barry S. , Qin Li-Xuan , Antonescu Cristina R. , Singer Samuel
Published: April 2023

PDF file - 259K, Copy number alterations in well-differentiated liposarcoma.
Related Article from Disentangling the Myeloma Web
Authors: Tonon Giovanni , Anderson Kenneth C.
Published: April 2023

Related Article from Disentangling the Myeloma Web
Supplementary Figure 1 from Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma
Authors: Xu Yang , Chenna Venugopal , Hu Chaoxin , Sun Hai-Xiang , Khan Mehtab , Bai Haibo , Yang Xin-Rong , Zhu Qing-Feng , Sun Yun-Fan , Maitra Anirban , Fan Jia , Anders Robert A.
Published: April 2023

PDF file - 216KB
Supplementary Table 9 from Opposing Effects of Runx2 and Estradiol on Breast Cancer Cell Proliferation: In Vitro Identification of Reciprocally Regulated Gene Signature Related to Clinical Letrozole Responsiveness
Authors: Chimge Nyam-Osor , Baniwal Sanjeev K. , Luo Jingqin , Coetzee Simon , Khalid Omar , Berman Benjamin P. , Tripathy Debu , Ellis Matthew J. , Frenkel Baruch
Published: April 2023

PDF file - 145K, Runx2 preferentially antagonizes genomic ER targets.
Supplementary Figure 1 from Population Pharmacokinetics of Busulfan in Children: Increased Evidence for Body Surface Area and Allometric Body Weight Dosing of Busulfan in Children
Authors: Trame Mirjam N. , Bergstrand Martin , Karlsson Mats O. , Boos Joachim , Hempel Georg
Published: April 2023

PDF file - 79KB, (A) Conditional weighted residuals over time after dose for the population model with allometric body weight as covariate on clearance and (B) conditional weighted residuals over time after dose for the population model with body surface area as covariate on clearance.
Supplementary Figure 4 from MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer
Authors: Migliore Cristina , Martin Valentina , Leoni Vera P. , Restivo Angelo , Atzori Luigi , Petrelli Annalisa , Isella Claudio , Zorcolo Luigi , Sarotto Ivana , Casula Giuseppe , Comoglio Paolo M. , Columbano Amedeo , Giordano Silvia
Published: April 2023

PDF file - 200K
CCR Translation for This Article from PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Authors: Fraser Michael , Zhao Helen , Luoto Kaisa R. , Lundin Cecilia , Coackley Carla , Chan Norman , Joshua Anthony M. , Bismar Tarek A. , Evans Andrew , Helleday Thomas , Bristow Robert G.
Published: April 2023

CCR Translation for This Article from PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Supplementary Figure 2 from Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome after Chemoradiotherapy of Lymph Node–Negative Cervical Cancer
Authors: Halle Cathinka , Lando Malin , Svendsrud Debbie Hege , Clancy Trevor , Holden Marit , Sundfør Kolbein , Kristensen Gunnar B. , Holm Ruth , Lyng Heidi
Published: April 2023

PDF file - 75K
Supplementary Table 3 from Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer
Authors: Gonzalez-Angulo Ana M. , Iwamoto Takayuki , Liu Shuying , Chen Huiqin , Do Kim-Anh , Hortobagyi Gabriel N. , Mills Gordon B. , Meric-Bernstam Funda , Symmans W. Fraser , Pusztai Lajos
Published: April 2023

PDF file - 194K
Supplementary Figure 8 from Preferential Replication of Systemically Delivered Oncolytic Vaccinia Virus in Focally Irradiated Glioma Xenografts
Authors: Advani Sunil J. , Buckel Lisa , Chen Nanhai G. , Scanderbeg Daniel J. , Geissinger Ulrike , Zhang Qian , Yu Yong A. , Aguilar Richard J. , Mundt Arno J. , Szalay Aladar A.
Published: April 2023

PDF file - 113K
Supplementary Figure Legends 1-2 from Notch1 Expression, Which Is Related to p65 Status, Is an Independent Predictor of Prognosis in Colorectal Cancer
Authors: Chu Dake , Zhou Yi , Zhang Zixi , Li Yuming , Li Jipeng , Zheng Jianyong , Zhang Hongwei , Zhao Qingchuan , Wang Weizhong , Wang Rui'an , Ji Gang
Published: April 2023

PDF file - 50K
Supplementary Table 1 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
Authors: Hsing Chung-Hsi , Cheng Hung-Chi , Hsu Yu-Hsiang , Chan Chien-Hui , Yeh Ching-Hua , Li Chien-Feng , Chang Ming-Shi
Published: April 2023

PDF file - 62K
Supplementary Figure 4 from A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non–Small Cell Lung Cancer
Authors: Soda Manabu , Isobe Kazutoshi , Inoue Akira , Maemondo Makoto , Oizumi Satoshi , Fujita Yuka , Gemma Akihiko , Yamashita Yoshihiro , Ueno Toshihide , Takeuchi Kengo , Choi Young Lim , Miyazawa Hitoshi , Tanaka Tomoaki , Hagiwara Koichi , Mano Hiroyuki
Published: April 2023

PDF file, 2146K, Transforming potential of a new variant of EML-4-ALK.
Supplementary Figure 2 from A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non–Small Cell Lung Cancer
Authors: Soda Manabu , Isobe Kazutoshi , Inoue Akira , Maemondo Makoto , Oizumi Satoshi , Fujita Yuka , Gemma Akihiko , Yamashita Yoshihiro , Ueno Toshihide , Takeuchi Kengo , Choi Young Lim , Miyazawa Hitoshi , Tanaka Tomoaki , Hagiwara Koichi , Mano Hiroyuki
Published: April 2023

PDF file, 2366K, Split FISH for ALK.
Supplementary Figure 3 from Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma
Authors: Malkoski Stephen P. , Haeger Sarah M. , Cleaver Timothy G. , Rodriguez Karen J. , Li Howard , Lu Shi-Long , Feser William J. , Barón Anna E. , Merrick Daniel , Lighthall Jessyka G. , Ijichi Hideaki , Franklin Wilbur , Wang Xiao-Jing
Published: April 2023

PDF file - 8.7MB
Supplementary Figure 1 from Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma
Authors: Malkoski Stephen P. , Haeger Sarah M. , Cleaver Timothy G. , Rodriguez Karen J. , Li Howard , Lu Shi-Long , Feser William J. , Barón Anna E. , Merrick Daniel , Lighthall Jessyka G. , Ijichi Hideaki , Franklin Wilbur , Wang Xiao-Jing
Published: April 2023

PDF file - 209K
Supplementary Methods, Tables 1-2 from Cure Models as a Useful Statistical Tool for Analyzing Survival
Authors: Othus Megan , Barlogie Bart , LeBlanc Michael L. , Crowley John J.
Published: April 2023

PDF file - 43K, Details of cure model parametrizations and summaries of regression results on the coefficient scale
Supplementary Figure 3 from A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo
Authors: Banh Alice , Xiao Nan , Cao Hongbin , Chen Che-Hong , Kuo Peiwen , Krakow Trevor , Bavan Brindha , Khong Brian , Yao Mike , Ha Chi , Kaplan Michael J. , Sirjani Davud , Jensen Kristin , Kong Christina S. , Mochly-Rosen Daria , Koong Albert C. , Le Quynh-Thu
Published: April 2023

PDF file - 408K
Supplementary Figure 5 from Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype
Authors: Wu Richard C. , Liu Shujuan , Chacon Jessica A. , Wu Sheng , Li Yufeng , Sukhumalchandra Pariya , Murray James L. , Molldrem Jeffrey J. , Hwu Patrick , Pircher Hanspeter , Lizée Gregory , Radvanyi Laszlo G.
Published: April 2023

PDF file - 74K, PD-1 expression is enriched in the CD8+CD27+CD57+ TIL subset freshly isolated from melanoma metastases (n=10).
Related Article from Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment Breaks
Authors: Ebos John M.L. , Pili Roberto
Published: April 2023

Related Article from Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment Breaks
Supplementary Figures 1-3 from Modulation of the Tumor Microvasculature by Phosphoinositide-3 Kinase Inhibition Increases Doxorubicin Delivery In Vivo
Authors: Qayum Naseer , Im Jaehong , Stratford Michael R. , Bernhard Eric J. , McKenna W. Gillies , Muschel Ruth J.
Published: April 2023

PDF file - 123K
Supplementary Figure 7 from Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
Authors: Piao Yuji , Liang Ji , Holmes Lindsay , Henry Verlene , Sulman Erik , de Groot John F.
Published: April 2023

PDF file, 925K, Activated STAT3 increases in the setting of bevacizumab resistance.
Supplementary Figure 5 from Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
Authors: Piao Yuji , Liang Ji , Holmes Lindsay , Henry Verlene , Sulman Erik , de Groot John F.
Published: April 2023

PDF file, 425K, Bevacizumab resistance promotes the infiltration of myeloid cells from the bone marrow.
Supplementary Figure 4 from Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
Authors: Piao Yuji , Liang Ji , Holmes Lindsay , Henry Verlene , Sulman Erik , de Groot John F.
Published: April 2023

PDF file, 854K, Bevacizumab resistance does not lead to an increase in cellular proliferation.
Supplementary Table 1 from CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
Authors: Walton Mike I. , Eve Paul D. , Hayes Angela , Valenti Melanie R. , De Haven Brandon Alexis K. , Box Gary , Hallsworth Albert , Smith Elizabeth L. , Boxall Kathy J. , Lainchbury Michael , Matthews Thomas P. , Jamin Yann , Robinson Simon P. , Aherne G. Wynne , Reader John C. , Chesler Louis , Raynaud Florence I. , Eccles Suzanne A. , Collins Ian , Garrett Michelle D.
Published: April 2023

PDF file, 76K, Supplementary Table 1 Kinome selectivity profile of CCT244747 CCT244747 was tested at 1 μM (140 enzymes) and 10 μM (121 enzymes) for inhibition of human kinases in a radiometric protein phosphorylation assay (MRC Protein Phosphorylation Unit, Dundee University, UK). Assays were conducted in the presence of ATP at the approximate Km,ATP for each kinase. Results are quoted as % control kinase activity remaining (100% = no inhibition, 0% = complete inhibition). Kinases inhibited by >50% at each concentration are highlighted. n.d. = not determined.
Supplementary Table 3 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
Authors: Miyazaki Yasumasa , Kosaka Takeo , Mikami Shuji , Kikuchi Eiji , Tanaka Nobuyuki , Maeda Takahiro , Ishida Masaru , Miyajima Akira , Nakagawa Ken , Okada Yasunori , Sato Yasufumi , Oya Mototsugu
Published: April 2023

PDF file - 31K, Univariate and multivariate analysis for recurrence-free survival and cancer-specific survival in 171 UTUC patients: We used the cutoff value of MVD � 80/mm2 and VASH1 density � 50/mm2 according to the mean values. The levels of VASH1 density were independent predictors for a decrease in recurrence-free (HR = 2.08) and cancer-specific survival (HR = 2.06)
Supplementary Figure Legend from CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
Authors: Walton Mike I. , Eve Paul D. , Hayes Angela , Valenti Melanie R. , De Haven Brandon Alexis K. , Box Gary , Hallsworth Albert , Smith Elizabeth L. , Boxall Kathy J. , Lainchbury Michael , Matthews Thomas P. , Jamin Yann , Robinson Simon P. , Aherne G. Wynne , Reader John C. , Chesler Louis , Raynaud Florence I. , Eccles Suzanne A. , Collins Ian , Garrett Michelle D.
Published: April 2023

PDF file, 68K.
Supplementary Table 1 from The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
Authors: Miyazaki Yasumasa , Kosaka Takeo , Mikami Shuji , Kikuchi Eiji , Tanaka Nobuyuki , Maeda Takahiro , Ishida Masaru , Miyajima Akira , Nakagawa Ken , Okada Yasunori , Sato Yasufumi , Oya Mototsugu
Published: April 2023

PDF file - 13K, Univariate and multivariate analysis for recurrence-free survival and cancer-specific survival of 175 UTUC patients: Multivariate analysis showed that high tumor grade, presence of LVI, positive pN and high VASH1 density were independent predictors of recurrence and cancer-specific survival
Supplementary Figure 3 from CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
Authors: Walton Mike I. , Eve Paul D. , Hayes Angela , Valenti Melanie R. , De Haven Brandon Alexis K. , Box Gary , Hallsworth Albert , Smith Elizabeth L. , Boxall Kathy J. , Lainchbury Michael , Matthews Thomas P. , Jamin Yann , Robinson Simon P. , Aherne G. Wynne , Reader John C. , Chesler Louis , Raynaud Florence I. , Eccles Suzanne A. , Collins Ian , Garrett Michelle D.
Published: April 2023

PDF file, 810K, Supplementary Figure 3 Characterisation of the effects of minimally toxic concentrations of CCT244747 alone or in combination with genotoxic agents (+) in HT29 and SW620 colon cancer cell lines. A, HT29 cells were treated with SN38 (100nM) or CCT244747 alone or in combination for 24h. B, SW620 cells were treated with gemcitabine (200nM) or CCT244747 alone or in combination for 24h. Cells were pre-treated with CCT244747 alone 1h prior to cytotoxic exposure. Protein expression was assessed by western blotting (40μg per lane) as described in Figure 2 and Materials and Methods.
Supplementary Figure 1 from CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
Authors: Walton Mike I. , Eve Paul D. , Hayes Angela , Valenti Melanie R. , De Haven Brandon Alexis K. , Box Gary , Hallsworth Albert , Smith Elizabeth L. , Boxall Kathy J. , Lainchbury Michael , Matthews Thomas P. , Jamin Yann , Robinson Simon P. , Aherne G. Wynne , Reader John C. , Chesler Louis , Raynaud Florence I. , Eccles Suzanne A. , Collins Ian , Garrett Michelle D.
Published: April 2023

PDF file, 58K, Supplementary Figure 1. Comparison of assays for measuring CHK1 potentiation of cytotoxic agents in vitro. A, Determination of CCT244747 GI50 alone or in combination with a fixed concentration (GI50) of gemcitabine or SN38 in SW620 colon tumor cells in vitro. The potentiation index (PI, ratio of SRB GI50 of CCT244747 alone : Combination GI50) was 4.0 and 14.8 for SN38 and gemcitabine, respectively (see Table 1 for mean�SD values). Survival curves for combinations were corrected to 100%. B, Determination of SN38 or gemcitabine GI50 alone or in combination with a fixed concentration of CCT244747 (1μM) in SW620 colon tumor cells in vitro. The potentiation index (PI, ratio of SRB GI50 of genotoxic alone : genotoxic + 1μM CCT244747) was 1.4 and 3.2 for gemcitabine and SN38, respectively. PI values for several independent experiments as shown in B were 1.2�0.058 and 2.9�0.33 (mean�SD, n=4) for SN38 and gemcitabine, respectively.
Supplementary Figure 1 from Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab
Authors: Smith Christopher G. , Fisher David , Claes Bart , Maughan Timothy S. , Idziaszczyk Shelley , Peuteman Gilian , Harris Rebecca , James Michelle D. , Meade Angela , Jasani Bharat , Adams Richard A. , Kenny Sarah , Kaplan Richard , Lambrechts Diether , Cheadle Jeremy P.
Published: April 2023

PDF - 89K, Inter-relationships between somatic mutations in the EGFR pathway and MSI-status in aCRC.
Supplementary Figure 2 from EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival
Authors: Smits Michiel , van Rijn Sjoerd , Hulleman Esther , Biesmans Dennis , van Vuurden Dannis G. , Kool Marcel , Haberler Christine , Aronica Eleonora , Vandertop W. Peter , Noske David P. , Würdinger Thomas
Published: April 2023

PDF file, 58KB, Kaplan-Meier analysis shows that medulloblastoma patients that have lower expression of DAB2IP have a lower overall survival probability in both metastatic and non-metastatic patients.
Supplementary Table 2 from Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
Authors: Smith Neil R. , Baker Dawn , Farren Matthew , Pommier Aurelien , Swann Ruth , Wang Xin , Mistry Sunita , McDaid Karen , Kendrew Jane , Womack Chris , Wedge Stephen R. , Barry Simon T.
Published: April 2023

PDF file - 52K, Clinicopathology data for human cancer specimens employed in tissue microarray analyses.
Supplementary Figure Legend from Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
Authors: Smith Neil R. , Baker Dawn , Farren Matthew , Pommier Aurelien , Swann Ruth , Wang Xin , Mistry Sunita , McDaid Karen , Kendrew Jane , Womack Chris , Wedge Stephen R. , Barry Simon T.
Published: April 2023

PDF file - 22K
Supplementary Table 2 from Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1α to Promote Hepatocellular Carcinoma Invasiveness
Authors: Huang Cheng , Ding Guangyu , Gu Chengyu , Zhou Jian , Kuang Ming , Ji Yuan , He Yifeng , Kondo Tadashi , Fan Jia
Published: April 2023

PDF file - 153K, Clinical characteristics of the 323 HCC Patients used in cohort 2
Supplementary Appendix and Methods from Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1α to Promote Hepatocellular Carcinoma Invasiveness
Authors: Huang Cheng , Ding Guangyu , Gu Chengyu , Zhou Jian , Kuang Ming , Ji Yuan , He Yifeng , Kondo Tadashi , Fan Jia
Published: April 2023

PDF file - 162K
Supplementary Figure 4 from Ontogeny and Sorafenib Metabolism
Authors: Zimmerman Eric I. , Roberts Justin L. , Li Lie , Finkelstein David , Gibson Alice , Chaudhry Amarjit S. , Schuetz Erin G. , Rubnitz Jeffrey E. , Inaba Hiroto , Baker Sharyn D.
Published: April 2023

PDF file, 73K, Inhibition of UGT1A9-mediated sorafenib metabolism by azole compounds.
Supplementary Table 1 from Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
Authors: Dunbier Anita K. , Ghazoui Zara , Anderson Helen , Salter Janine , Nerurkar Ashutosh , Osin Peter , A'hern Roger , Miller William R. , Smith Ian E. , Dowsett Mitch
Published: April 2023

PDF file - 44K, Patient demographics.
Supplementary Table 4 from Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
Authors: Wei Rongrong , Huang Guo-Liang , Zhang Mei-Yin , Li Bin-Kui , Zhang Hui-Zhong , Shi Ming , Chen Xiao-Qian , Huang Long , Zhou Qing-Ming , Jia Wei-Hua , Zheng X.F. Steven , Yuan Yun-Fei , Wang Hui-Yun
Published: April 2023

PDF file, 125K, Univariate and multivariate analysis of features associated with overall survival.
Supplementary Figure 1 from Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor–Modified T Cells
Authors: Kong Seogkyoung , Sengupta Sadhak , Tyler Betty , Bais Anthony J. , Ma Qiangzhong , Doucette Saryn , Zhou Jinyuan , Sahin Ayguen , Carter Bob S. , Brem Henry , Junghans Richard P. , Sampath Prakash
Published: April 2023

PDF file, 136K, Bar graph representing IL2 secretion by untransduced or IL13-CAR transduced T cells upon co-culturing.
Supplementary Figures 1-6 from Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes
Authors: Tafreshi Narges K. , Bui Marilyn M. , Bishop Kellsey , Lloyd Mark C. , Enkemann Steven A. , Lopez Alexis S. , Abrahams Dominique , Carter Bradford W. , Vagner Josef , Grobmyer Stephen R. , Gillies Robert J. , Morse David L.
Published: April 2023

PDF file - 1.5MB
Supplementary Figure 2 from Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
Authors: Wei Rongrong , Huang Guo-Liang , Zhang Mei-Yin , Li Bin-Kui , Zhang Hui-Zhong , Shi Ming , Chen Xiao-Qian , Huang Long , Zhou Qing-Ming , Jia Wei-Hua , Zheng X.F. Steven , Yuan Yun-Fei , Wang Hui-Yun
Published: April 2023

PDF file, 131K, The relationship between 20-miRNA signature risk score and survival status of HCC patients in combination of training and test sets.
Supplementary Figure 7 from MicroRNA-494 Downregulates KIT and Inhibits Gastrointestinal Stromal Tumor Cell Proliferation
Authors: Kim Won Kyu , Park Misun , Kim Young-Kook , Tae You Kwon , Yang Han-Kwang , Lee Jae Myun , Kim Hoguen
Published: April 2023

PDF file - 1.8MB
Supplementary Figure 2 from MicroRNA-494 Downregulates KIT and Inhibits Gastrointestinal Stromal Tumor Cell Proliferation
Authors: Kim Won Kyu , Park Misun , Kim Young-Kook , Tae You Kwon , Yang Han-Kwang , Lee Jae Myun , Kim Hoguen
Published: April 2023

PDF file - 3.0MB
Supplementary Methods from microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics
Authors: Navarro Alba , Clot Guillem , Prieto Miriam , Royo Cristina , Vegliante Maria Carmela , Amador Virginia , Hartmann Elena , Salaverria Itziar , Beà Sílvia , Martín-Subero Jose Ignacio , Rosenwald Andreas , Ott German , Wiestner Adrian , Wilson Wyndham H. , Campo Elías , Hernández Luis
Published: April 2023

PDF file - 112K
Supplementary Table 2 from Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival
Authors: Boyd Kevin D. , Ross Fiona M. , Walker Brian A. , Wardell Christopher P. , Tapper William J. , Chiecchio Laura , Dagrada GianPaolo , Konn Zoe J. , Gregory Walter M. , Jackson Graham H. , Child J. Anthony , Davies Faith E. , Morgan Gareth J.
Published: April 2023

PDF file - 20KB
Supplementary Table 1C from Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
Authors: Crane Courtney A. , Han Seunggu J. , Ahn Brian , Oehlke Jessica , Kivett Valerie , Fedoroff Anne , Butowski Nicholas , Chang Susan M. , Clarke Jennifer , Berger Mitchel S. , McDermott Michael W. , Prados Michael D. , Parsa Andrew T.
Published: April 2023

PDF file, 23K, Adjuvant Therapies Prior to and After Vaccination.
Supplementary Figure 2 from Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis
Authors: Tone Alicia A. , Virtanen Carl , Shaw Patricia , Brown Theodore J.
Published: April 2023

PDF file, 25K, Impact of DAB2 and BRCA1 on TNFα-induced BIRC3 expression.
Supplementary Figure Legends from VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy
Authors: Riquelme Erick , Suraokar Milind , Behrens Carmen , Lin Heather Y. , Girard Luc , Nilsson Monique B. , Simon George , Wang Jing , Coombes Kevin R. , Lee J. Jack , Hong Waun Ki , Heymach John , Minna John D. , Wistuba Ignacio I.
Published: April 2023

PDF file - 89KB
Supplementary Figure 1 from The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy
Authors: Somaiah Navita , Yarnold John , Daley Frances , Pearson Ann , Gothard Lone , Rothkamm Kai , Helleday Thomas
Published: April 2023

PDF file, 105K, Serial 3�m sections of epidermis stained with Cyclin A and p21 (brown) and counterstained with haematoxylin (blue). Overlay of serial sections using MATLAB 7.9 R2009b software shows strong uptake of p21 in Cyclin A positive cells.
Supplementary Figure Legend from Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
Authors: Sangai Takafumi , Akcakanat Argun , Chen Huiqin , Tarco Emily , Wu Yun , Do Kim-Anh , Miller Todd W. , Arteaga Carlos L. , Mills Gordon B. , Gonzalez-Angulo Ana Maria , Meric-Bernstam Funda
Published: April 2023

PDF file, 43K.
Supplementary Table 1 from Antitumor Activity of Targeted and Cytotoxic Agents in Murine Subcutaneous Tumor Models Correlates with Clinical Response
Authors: Wong Harvey , Choo Edna F. , Alicke Bruno , Ding Xiao , La Hank , McNamara Erin , Theil Frank-Peter , Tibbitts Jay , Friedman Lori S. , Hop Cornelis E.C.A. , Gould Stephen E.
Published: April 2023

PDF file, 74KB, Dose and Schedule Information for Xenograft/ Allograft Studies for Anti-Cancer Agents.
Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
Authors: Li Ling , Tang Wenhua , Wu Xiaoqing , Karnak David , Meng Xiaojie , Thompson Rachel , Hao Xinbao , Li Yongmin , Qiao Xiaotan T. , Lin Jiayuh , Fuchs James , Simeone Diane M. , Chen Zhi-Nan , Lawrence Theodore S. , Xu Liang
Published: April 2023

PDF file - 451K, Figure S5: CyPA promotes HAb18G/CD147-CD44s-pSTAT3 signaling and correlated pancreatic cell growth (related to Figure 2, 3). Figure S6: HAb18G/CD147 and CD44s are co-expressed and associated in pancreatic cancer (related to Figure 4).
Supplementary Table 4 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors: Harbst Katja , Staaf Johan , Lauss Martin , Karlsson Anna , Måsbäck Anna , Johansson Iva , Bendahl Pär-Ola , Vallon-Christersson Johan , Törngren Therese , Ekedahl Henrik , Geisler Jürgen , Höglund Mattias , Ringnér Markus , Lundgren Lotta , Jirström Karin , Olsson Håkan , Ingvar Christian , Borg Åke , Tsao Hensin , Jönsson Göran
Published: April 2023

PDF file - 95K, The expression values for these genes were averaged across GSE22155 samples in the two classes thereby providing us with two distinct centroids
Supplementary Table 1 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors: Harbst Katja , Staaf Johan , Lauss Martin , Karlsson Anna , Måsbäck Anna , Johansson Iva , Bendahl Pär-Ola , Vallon-Christersson Johan , Törngren Therese , Ekedahl Henrik , Geisler Jürgen , Höglund Mattias , Ringnér Markus , Lundgren Lotta , Jirström Karin , Olsson Håkan , Ingvar Christian , Borg Åke , Tsao Hensin , Jönsson Göran
Published: April 2023

PDF file - 51K, Univariate analyses in the whole cohort and in melanomas with a Breslow thickness > 2mm
Supplementary Figure Legends 53 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors: Harbst Katja , Staaf Johan , Lauss Martin , Karlsson Anna , Måsbäck Anna , Johansson Iva , Bendahl Pär-Ola , Vallon-Christersson Johan , Törngren Therese , Ekedahl Henrik , Geisler Jürgen , Höglund Mattias , Ringnér Markus , Lundgren Lotta , Jirström Karin , Olsson Håkan , Ingvar Christian , Borg Åke , Tsao Hensin , Jönsson Göran
Published: April 2023

PDF file - 95K
Supplementary Figure 2 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors: Harbst Katja , Staaf Johan , Lauss Martin , Karlsson Anna , Måsbäck Anna , Johansson Iva , Bendahl Pär-Ola , Vallon-Christersson Johan , Törngren Therese , Ekedahl Henrik , Geisler Jürgen , Höglund Mattias , Ringnér Markus , Lundgren Lotta , Jirström Karin , Olsson Håkan , Ingvar Christian , Borg Åke , Tsao Hensin , Jönsson Göran
Published: April 2023

PDF file - 116K, Among the set of 36 BRAF-mutated cases, high-grade tumors showed worse survival than low-grade lesions